Intelligyn omdelade detta
Invited Speaker sharing our recent research, to the XV SOCHUMB congress in Santiago de Chile. Thanks to the organizers for a fantastic event!
At Intelligyn, we are making a measurable impact in women's health. Our innovative AI diagnostic support tool and education platform, SonoQz, empower examiners to provide precise diagnostics for every woman with an ovarian tumour. We are reducing patient anxiety, enhancing patient outcomes, and streamlining healthcare efficiency – all to create real, meaningful progress in the field of women's healthcare.
Extern länk för Intelligyn
Stockholm, SE
Palo Alto, California, US
Intelligyn omdelade detta
Invited Speaker sharing our recent research, to the XV SOCHUMB congress in Santiago de Chile. Thanks to the organizers for a fantastic event!
Would you like to differentiate benign from malignant ovarian tumours on ultrasound with greater confidence? In time for Ovarian Cancer Awareness month, we're excited to share the results of a recent study on our education platform which you can find here: https://lnkd.in/gVsudngT The study demonstrates that our interactive, case-based learning platform designed for training clinicians in ovarian tumour diagnosis significantly improves diagnostic specificity from 70% to 89%! Our goal is to bridge the expertise gap and better equip all ultrasound users with the skills to improve ovarian cancer diagnosis. Team Intelligyn invites you to sign up on our website https://www.intelligyn.ai/ to stay informed as we prepare for the upcoming release of our education platform. Simply scroll down to the bottom of our homepage and click the "Sign Up" button and you'll hear from us soon. #OvarianCancerAwarenessMonth #WomensHealth #FemTech #MedTech #OvarianCancer #Education
More proud news for everyone's Friday! Our team member Filip Christiansen has been invited to present our study "AI-driven ultrasound detection of ovarian cancer that generalises” at Radiological Society of North America (RSNA) in Chicago (December 1-5). We'll share the time and location details closer to the event!
I am excited to share that I have been invited to present our work titled 'AI-driven ultrasound detection of ovarian cancer that generalizes: an international multicentre validation study' at the 110th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago in December, and that our abstract was selected from over 12,000 submissions. I want to thank everyone who has contributed to this work, including Elisabeth Epstein, Kevin Smith, Pawel Herman, Emir Konuk, Adithya Raju, Robert Welch, Joana Palés Huix, Lasse Stahnke, Artur Czekierdowski, Francesco Paolo Giuseppe Leone, Lucia Anna Haak, Robert Fruscio, Adrius Gaurilcikas, Dorella Franchi, Daniela Fischerová, Elisa Mor, Luca Savelli, Maria Àngela Pascual, Marek Kudla, Guerriero Stefano Cagliari, Francesca Buonomo, Karina Liuba, nina montik, Juan Luis Alcazar Zambrano, Ekaterini Domali, Nelinda Catherine Pangilinan, Chiara Carella, Maria Munaretto, Petra Šašková, Debora Verri, Chiara Visenzi, Emma Bernell, Rasmus Green, Sanaa Jamil, Stella Wickström, Bartłomiej Barczyński, Dominika Bednářová, Ida Belfrage, Emelie Bessfelt, Emma Björn, Sonia Bove, Sofia Bussolaro, giorgia garganese, Giovanni Delli Carpini, Paolo Donarini, Sara Doroldi, Oľga Dubová, Filip Frühauf, Chris April Garcia, Dovile Gaurilcikiene, Migle Gedgaudaite, Agnė Lukošienė, Roberta Marie Gentile, Jitka Klikarová, Roman Kocian, Klara Krantz Andersson, Emmeline Krook, Francesco Mezzapesa, Zuzana Michalcová, Anna Minelli, Cristiana Paniga, Ida Pino, Vilma Ravelli, Camilla Robertsson Grossmann, Lottie Säker, Carolina Maria Sassu, Luisa Scalvi, Linnea Skogvard, Erica Smedberg, Mateusz Stolecki, Michał Szpringer, Noemi Tiszlavicz, Beatriz Valero, Julio Vara García, Panagiotis Vlastarakos, Roberto Zanini, and Bettina Zsikai. Also, shoutout to Vetenskapsrådet / Swedish Research Council, Cancerfonden, and Region Stockholm who have supported our work.
We are incredibly proud to share that our teammate Filip Christiansen, a dedicated researcher at Karolinska Institutet, and an integral part of Intelligyn, has had his research team's abstract titled 'AI-driven ultrasound detection of ovarian cancer that generalizes: an international multicentre validation study' selected as one of the five top abstracts at the 34th World Congress on Ultrasound in Obstetrics & Gynecology. Chosen from over 1,400 submissions across 78 countries, Filip has also been shortlisted for the prestigious 'Young Investigator Award' and will be presenting his work at the ISUOG International Society of Ultrasound in Obstetrics and Gynecology global congress in Budapest this September. Congratulations to Filip Christiansen and his team on your hard work and talent being recognised. We can't wait to see the impact your research will continue to make for the bright future of AI-driven solutions in women's health!
Innehållet är inte tillgängligt här
Få tillgång till det här innehållet och mycket mer i LinkedIns app
Intelligyn is excited to announce our collaboration with Femcare, a leading private gynecological provider in Sweden 🇸🇪💫. Both Intelligyn and Femcare share a vision of transforming women's healthcare, making this partnership a perfect alliance for progress. Stay tuned for updates on our research progress and the future impact of AI in women's healthcare! Karl-Johan Sturesson #Intelligyn #Femcare #WomensHealth #AIInHealthcare #OvarianTumours
We're pleased to announce that Intelligyn has secured additional funding from Vinnova 🤝. This funding supports our regulatory activities 🔍 and work towards certification as a Class IIb medical device ✅. From the entire team Intelligyn, thank you Vinnova for supporting Intelligyn's mission!
Intelligyn recently partnered with Hyper Island's talented students highlighting how IntelligynAI, acting as a copilot, can enhance the diagnostic accuracy of ovarian tumours, streamline patient care, and optimise healthcare resources. Take a look and share your thoughts! (Please note that the solution is not yet approved for diagnostic use outside of a clinical research setting). Hilvan Jabar Iris Hallberg Noel Gora Izabelle Brindstedt @Oskar Alm #Intelligyn #IntelligynAI #HyperIsland #HealthcareInnovation #DiagnosticAccuracy #OvarianTumors #AIinHealthcare #PatientCare #HealthcareResources #Copilot #MedTech #MedicalTechnology #Partnership #Collaboration #DigitalHealth #FutureOfHealthcare
A recent systematic review and meta-analysis published in the journal Applied Sciences highlights the significant potential of AI-assisted ultrasound diagnostics in gynecology, aligning perfectly with our mission at Intelligyn. The article features a study by Filip Christiansen, PhD student and lead AI scientist, and Professor Elisabeth Epstein, CEO and Head of Research, which compares the performance of AI models like IntelligynAI with expert subjective assessments for discriminating adnexal masses. We're excited to see our research recognised in this comprehensive analysis, as it emphasises the ability of AI to improve diagnostic accuracy and efficiency. Read the article here: https://lnkd.in/g64VPYn6 #IntelligynAI #WomensHealth #Gynecology #AI #UltrasoundDiagnostics #DiagnosticAccuracy #HealthTech #MedicalResearch #AppliedSciences #Innovation #GroundbreakingResearch #Collaboration #ExpertAssessment #AdnexalMasses #Efficiency #ImprovingOutcomes #PatientCare
Team #Intelligyn pitcing at Drive Investors day supported by #KIInnovations. Fantastic opportunity to meet other startups and Investors! #AI #diagnoaticsupport #ovariancancer
Intelligyn is excited to have been selected as a finalist for the Techarenan Pitch40 competition. Come support us on Thursday 22nd February at the Pitch Stage, in the centre of the Tech Arena (Friends Arena) in Stockholm, Sweden.